BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36043756)

  • 21. Interleukin-6 mediates PSAT1 expression and serine metabolism in TSC2-deficient cells.
    Wang J; Filippakis H; Hougard T; Du H; Ye C; Liu HJ; Zhang L; Hindi K; Bagwe S; Nijmeh J; Asara JM; Shi W; El-Chemaly S; Henske EP; Lam HC
    Proc Natl Acad Sci U S A; 2021 Sep; 118(39):. PubMed ID: 34544857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Wild-type IDH1 maintains NSCLC stemness and chemoresistance through activation of the serine biosynthetic pathway.
    Zhang C; Yu JJ; Yang C; Yuan ZL; Zeng H; Wang JJ; Shang S; Lv XX; Liu XT; Liu J; Xue Q; Cui B; Tan FW; Hua F
    Sci Transl Med; 2023 Dec; 15(726):eade4113. PubMed ID: 38091408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments.
    Zheng MJ; Li X; Hu YX; Dong H; Gou R; Nie X; Liu Q; Ying-Ying H; Liu JJ; Lin B
    J Cell Physiol; 2019 Jul; 234(7):11023-11036. PubMed ID: 30633343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone metastatic breast cancer cells display downregulation of PKC-ζ with enhanced glutamine metabolism.
    Tandon M; Othman AH; Winogradzki M; Pratap J
    Gene; 2021 Apr; 775():145419. PubMed ID: 33444686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of microRNA-195-5p reduces cisplatin resistance and angiogenesis in ovarian cancer by inhibiting the PSAT1-dependent GSK3β/β-catenin signaling pathway.
    Dai J; Wei R; Zhang P; Kong B
    J Transl Med; 2019 Jun; 17(1):190. PubMed ID: 31171023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphoserine Aminotransferase has Conserved Active Site from Microbes to Higher Eukaryotes with Minor Deviations.
    Singh RK; Kumar D; Gourinath S
    Protein Pept Lett; 2021; 28(9):996-1008. PubMed ID: 33588715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and validation of PSAT1 as a potential prognostic factor for predicting clinical outcomes in patients with colorectal carcinoma.
    Qian C; Xia Y; Ren Y; Yin Y; Deng A
    Oncol Lett; 2017 Dec; 14(6):8014-8020. PubMed ID: 29344244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An integrated pan-cancer analysis of PSAT1: A potential biomarker for survival and immunotherapy.
    Feng M; Cui H; Tu W; Li L; Gao Y; Chen L; Li D; Chen X; Xu F; Zhou C; Cao Y
    Front Genet; 2022; 13():975381. PubMed ID: 36105075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic microRNAs associated with phosphoserine aminotransferase 1 in gastric cancer as markers of bone metastasis.
    Ma J; Zhu M; Ye X; Wu B; Wang T; Ma M; Li T; Zhang N
    Front Genet; 2022; 13():959684. PubMed ID: 36061202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lineage-specific silencing of PSAT1 induces serine auxotrophy and sensitivity to dietary serine starvation in luminal breast tumors.
    Choi BH; Rawat V; Högström J; Burns PA; Conger KO; Ozgurses ME; Patel JM; Mehta TS; Warren A; Selfors LM; Muranen T; Coloff JL
    Cell Rep; 2022 Jan; 38(3):110278. PubMed ID: 35045283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting PSAT1 to mitigate metastasis in tumors with p53-72Pro variant.
    Jiang J; Chen HN; Jin P; Zhou L; Peng L; Huang Z; Qin S; Li B; Ming H; Luo M; Xie N; Gao W; Nice EC; Yu Q; Huang C
    Signal Transduct Target Ther; 2023 Feb; 8(1):65. PubMed ID: 36788227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of
    Huang SP; Chan YC; Huang SY; Lin YF
    Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31861486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-424 targets AKT3 and PSAT1 and has a tumor-suppressive role in human colorectal cancer.
    Fang Y; Liang X; Xu J; Cai X
    Cancer Manag Res; 2018; 10():6537-6547. PubMed ID: 30555259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance and function of the vacuolar H+-ATPase subunit V1E1 in esophageal squamous cell carcinoma.
    Son SW; Kim SH; Moon EY; Kim DH; Pyo S; Um SH
    Oncotarget; 2016 Aug; 7(31):49334-49348. PubMed ID: 27384996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis.
    Pollari S; Käkönen SM; Edgren H; Wolf M; Kohonen P; Sara H; Guise T; Nees M; Kallioniemi O
    Breast Cancer Res Treat; 2011 Jan; 125(2):421-30. PubMed ID: 20352489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of serine metabolism in lung cancer: From oncogenesis to tumor treatment.
    Zhou X; Tian C; Cao Y; Zhao M; Wang K
    Front Genet; 2022; 13():1084609. PubMed ID: 36699468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA SBF2-AS1: A Budding Star in Various Cancers.
    Tan F; Chen J; Wang B; Du Z; Mou J; Wu Y; Liu Y; Zhao F; Yuan C
    Curr Pharm Des; 2022; 28(18):1513-1522. PubMed ID: 35440300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regorafenib induces lethal autophagy arrest by stabilizing PSAT1 in glioblastoma.
    Jiang J; Zhang L; Chen H; Lei Y; Zhang T; Wang Y; Jin P; Lan J; Zhou L; Huang Z; Li B; Liu Y; Gao W; Xie K; Zhou L; Nice EC; Peng Y; Cao Y; Wei Y; Wang K; Huang C
    Autophagy; 2020 Jan; 16(1):106-122. PubMed ID: 30909789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serine Biosynthesis Is a Metabolic Vulnerability in IDH2-Driven Breast Cancer Progression.
    Barnabas GD; Lee JS; Shami T; Harel M; Beck L; Selitrennik M; Jerby-Arnon L; Erez N; Ruppin E; Geiger T
    Cancer Res; 2021 Mar; 81(6):1443-1456. PubMed ID: 33500247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
    J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.